Clinical trial
Comparison of the Effects of Nintedanib and Pirfenidone on Pulmonary Function Test Parameters and Radiological Findingsin Patients With Pulmonary Fibrosis
NCT06650774 is registered in ClinicalTrials.gov with Karadeniz Technical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of the Effects of Nintedanib and Pirfenidone on Pulmonary Function Test Parameters and Radiological Findingsin Patients With Pulmonary Fibrosis
- Lead sponsor
- Karadeniz Technical University
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 15, 2024
- Completion date
- September 30, 2024
- Enrollment
- 152 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
idiopathic pulmonary fibrosis (ipf)